ghk cu peptide injection or serum GHK-Cu Topical vs GHK-CU - Research Peptide -

Start: Begin at 200 mcg once daily and increase by ~100 mcg each week as tolerated

Certificate of Analysis Each batch is tested by an independent third-party laboratory for: Peptide identity verification Purity analysis via HPLC (99%) Microbial contaminant screening Heavy metal analysis Residual solvent testing Key Ingredients Tripeptide-copper complex studied for its ability to modulate over 4,000 human genes

GLOW Peptide Regulatory Status As of June 2026, none of the three GLOW compounds (BPC-157, TB-500, GHK-Cu) are FDA-approved for injectable human use

AOD-9604 is not FDA-approved for any indication, and all use represents off-label application requiring informed medical decision-making